Jennifer Nelms

Title: The Innovative Journey of Jennifer Nelms

Introduction

Jennifer Nelms is a notable inventor based in Des Plaines, IL (US). She has made significant contributions to the field of biotechnology, particularly in enzyme engineering. Her work focuses on developing enzyme analogues that exhibit resistance to feedback inhibition, which has important implications for various applications in biochemistry and molecular biology.

Latest Patents

Jennifer holds a patent for "DNA encoding PHE a feedback inhibition resistant enzyme analogues." This patent discloses DNA sequences involving bonding deletion, substitution, and/or addition analogs of the E. coli enzyme, chorismate mutase/prephenate dehydratase (CMPD). The preferred expression products include [des-Gln.sup.307, des-Ala.sup.308, des-Gly.sup.309, des-Ala.sup.310] CMPD; [Leu.sup.306] CMPD; [des-Thr.sup.304, Lys.sup.305, des-Gln.sup.306] CMPD; and [Cys.sup.309] CMPD. These products display enzymatic activity similar to the wild type enzyme but are more resistant to inhibition in the presence of phenylalanine.

Career Highlights

Throughout her career, Jennifer has worked with prominent companies, including the NutraSweet Company and Ian G. Fotheringham. Her experience in these organizations has allowed her to refine her skills and contribute to innovative projects in the field of enzyme research.

Collaborations

Jennifer has collaborated with Ian G. Fotheringham, who has been a significant figure in her professional journey. Their partnership has led to advancements in enzyme technology and has fostered a productive exchange of ideas.

Conclusion

Jennifer Nelms exemplifies the spirit of innovation in biotechnology through her groundbreaking work on enzyme analogues. Her contributions continue to influence the field and inspire future research endeavors.